Page last updated: 2024-08-23

paclitaxel and Leukemia, Prolymphocytic

paclitaxel has been researched along with Leukemia, Prolymphocytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrams, SL; Bäsecke, J; Chappell, W; Donia, M; Libra, M; Martelli, AM; McCubrey, JA; Nicoletti, F; Shelton, JG; Steelman, LS; Stivala, F	1

Other Studies

1 other study(ies) available for paclitaxel and Leukemia, Prolymphocytic

Article	Year
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy. Cell cycle (Georgetown, Tex.), 2010, Volume: 9, Issue:9 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Chromones; Doxorubicin; G1 Phase; Interleukin-3; Intracellular Signaling Peptides and Proteins; Leukemia, Prolymphocytic; Mice; Mitogen-Activated Protein Kinase Kinases; Morpholines; Nitriles; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2010

Article

Year

Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Cell cycle (Georgetown, Tex.), 2010, Volume: 9, Issue:9

Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Chromones; Doxorubicin; G1 Phase; Interleukin-3; Intracellular Signaling Peptides and Proteins; Leukemia, Prolymphocytic; Mice; Mitogen-Activated Protein Kinase Kinases; Morpholines; Nitriles; Paclitaxel; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2010